Moment on the Lips, a Lifetime on the Lungs?: Improving Models of Group 2 Pulmonary Hypertension
- PMID: 31518172
- PMCID: PMC6746245
- DOI: 10.1161/CIRCRESAHA.119.315478
Moment on the Lips, a Lifetime on the Lungs?: Improving Models of Group 2 Pulmonary Hypertension
Keywords: Editorial; metabolic syndrome; peripheral vascular diseases; right ventricles; vascular remodeling.
Comment on
-
Metabolic Syndrome Exacerbates Pulmonary Hypertension due to Left Heart Disease.Circ Res. 2019 Aug 2;125(4):449-466. doi: 10.1161/CIRCRESAHA.118.314555. Epub 2019 Jun 3. Circ Res. 2019. PMID: 31154939
References
-
- Gerges M, Gerges C, Pistritto A-M, Lang MB, Trip P, Jakowitsch J, Binder T, Lang IM. Pulmonary Hypertension in Heart Failure. Epidemiology, Right Ventricular Function, and Survival. American Journal of Respiratory and Critical Care Medicine. 2015;192:1234–1246. - PubMed
-
- Gerges C, Gerges M, Lang MB, Zhang Y, Jakowitsch J, Probst P, Maurer G, Lang IM. Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in “out-of-proportion” pulmonary hypertension. CHEST. 2013;143:758–766. - PubMed
-
- Gorter TM, van Veldhuisen DJ, Voors AA, Hummel YM, Lam CSP, Berger RMF, van Melle JP, Hoendermis ES. Right ventricular-vascular coupling in heart failure with preserved ejection fraction and pre- vs. post-capillary pulmonary hypertension. Eur Heart J Cardiovasc Imaging. 2017;61:1498. - PubMed
-
- Califf RM, Adams KF, McKenna WJ, Gheorghiade M, Uretsky BF, McNulty SE, Darius H, Schulman K, Zannad F, Handberg-Thurmond E, et al. A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST). American Heart Journal. 1997;134:44–54. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
